HomeCPRX • NASDAQ
add
Catalyst Pharmaceuticals Inc
Previous close
$24.79
Day range
$24.63 - $25.43
Year range
$19.05 - $26.58
Market cap
3.03B USD
Avg Volume
1.26M
P/E ratio
14.71
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 152.61M | 7.61% |
Operating expense | 62.89M | 17.46% |
Net income | 52.70M | -5.79% |
Net profit margin | 34.53 | -12.45% |
Earnings per share | 0.68 | -2.86% |
EBITDA | 71.38M | -1.27% |
Effective tax rate | 26.71% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 709.17M | 37.02% |
Total assets | 1.10B | 29.66% |
Total liabilities | 149.71M | 20.95% |
Total equity | 954.27M | — |
Shares outstanding | 122.12M | — |
Price to book | 3.18 | — |
Return on assets | 14.35% | — |
Return on capital | 16.45% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 52.70M | -5.79% |
Cash from operations | 44.89M | -36.66% |
Cash from investing | -32.00K | 63.64% |
Cash from financing | -25.58M | -677.04% |
Net change in cash | 19.28M | -74.37% |
Free cash flow | 49.93M | -16.37% |
About
Founded
2002
Headquarters
Website
Employees
182
